Superior Group of Companies' InSpan Device Sets New Benchmark in Spinal Surgery Innovation
- Superior Group's InSpan interspinous fixation device significantly outperforms the Aspen® IFD in surgical strength and stability.
- InSpan shows a 94.8% increase in resistance to pullout forces, enhancing surgical success rates and patient recovery.
- Superior Group's commitment to innovation in spinal surgery technology sets new industry benchmarks for patient care.
### InSpan's Interspinous Fixation Device Sets New Standards in Spinal Surgery
A recent biomechanical study published in The Journal of Spine Surgery reveals that Superior Group of Companies' InSpan interspinous fixation device (IFD) significantly outperforms its competitor, the Aspen® IFD, now owned by Highridge Medical. Conducted by Dr. Kingsley R. Chin, a Harvard-trained orthopedic spine surgeon and CEO of KIC Ventures, the study showcases InSpan's advanced dual-locking symmetrical design. This innovative approach results in nearly double the fixation strength compared to the Aspen device, which is a crucial factor for successful surgical outcomes. The findings indicate that InSpan's design not only provides enhanced initial stability but also promotes long-term patient resilience.
The study quantifies the performance advantage of InSpan over Aspen, demonstrating a 94.8% increase in resistance to pullout forces during static testing. Additionally, it requires 60.7% more force to disassemble than pristine Aspen devices, and an astonishing 400% more force under used conditions. These metrics underscore the effectiveness of InSpan's engineering, which aims to improve surgical success rates and patient recovery times. The results are a testament to the commitment of Superior Group of Companies to innovate and advance spinal surgery technologies, setting new benchmarks in the industry.
Moreover, the study's findings reveal that failures in testing occur not at the implant level but rather at the interface with the testing material, highlighting the superior design of InSpan's plate and tooth structure. This insight provides a strong scientific basis for the performance claims associated with InSpan's interspinous fixation device. The collaborative effort of a multidisciplinary team, including not only Dr. Chin but also Dr. Erik Spayde, Dr. William M. Costigan, and CTO Vito Lore, adds credibility to this groundbreaking research, marking a significant milestone in the evolution of spinal fixation solutions.
In related news, Hardee's® is expanding its menu with two new offerings: the BBQ Pulled Pork Frisco and the Smoked Sausage, Egg and Cheese Biscuit, set to launch on June 18, 2025. This expansion reflects Hardee’s dedication to quality and innovation in fast food, partnering with renowned meat producers to deliver a rich flavor experience.
Through these strategic advancements in both surgical technology and culinary offerings, Superior Group of Companies continues to assert its leadership across diverse sectors, underscoring a commitment to quality and excellence.